Inhibrx Biosciences, Inc. INBX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Inhibrx Biosciences, Inc.’s reported figures.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s enterprise value?
- Inhibrx Biosciences, Inc. (INBX) reported enterprise value of $1B in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s enterprise value changed year-over-year?
- Inhibrx Biosciences, Inc.'s enterprise value increased by 982.1% year-over-year, from $92.53M to $1B.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s enterprise value?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s enterprise value has grown at a 53.2% compound annual growth rate (CAGR), from $482.3M to $1.13B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.